AZD0901 in participants with advanced solid tumours expressing Claudin18.2

Trial Identifier:	D9800C00001
Sponsor:	AstraZeneca
Start Date:	December 2023
Primary Completion Date:	December 2025
Study Completion Date:	December 2026
Condition:	Liver Cancer; Gastric Cancer; Esophageal cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
AU	Melbourne, AU, 3000
AU	Murdoch, AU, WA6150
AU	Randwick, AU, 2031
CA, ON	Toronto, ON, CA, M5G 2M9
CA, QC	Montreal, QC, CA, H3G 1A4
CA, QC	Sherbrooke, QC, CA, J1G 2E8
ES	Barcelona, ES, 08035
ES	Madrid, ES, 28007
ES	Madrid, ES, 28040
GE	Tbilisi, GE, 0112
JP	Chuo-ku, JP, 104-0045
JP	Kashiwa, JP, 227-8577
JP	Kitaadachi-gun, JP, 362-0806
JP	Koto-ku, JP, 135-8550
JP	Nagoya-shi, JP, 464-8681
JP	Osakasayama-shi, JP, 589-8511
KR	seoul, KR, 06351
KR	Seoul, KR, 05505
KR	Seoul, KR, 03080
KR	Seoul, KR, 03722
MD	Chisinau, MD, MD-2025
MY	George Town, MY, 10450
MY	Johor Bahru, MY, 81100
MY	Kuala Lumpur, MY, 59100
MY	Kuching, MY, 93586
MY	Selangor, MY, 62250
PL	Kraków, PL, 31-501
PL	Warszawa, PL, 02-034
SG	Bukit Merah, SG, 169610
SG	Singapore, SG, 119074
SG	Singapore, SG, 308433
SG	Singapore, SG, 329563
TW	Kaohsiung, TW, 80756
TW	Taichung, TW, 404
TW	Tainan City, TW, 70403
TW	Taipei City, TW, 11217
TW	Taoyuan, TW, 00333
US, CA	Orange, CA, US, 92868
US, CA	Palo Alto, CA, US, 94304
US, CA	Santa Rosa, CA, US, 95403
US, KY	Louisville, KY, US, 40202
US, NY	Commack, NY, US, 11725
US, RI	Providence, RI, US, 02903
US, TX	Houston, TX, US, 77030

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company